NCT06256614 Washed Microbiota Transplantation for Type 1 Diabetes Mellitus
| NCT ID | NCT06256614 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Second Hospital of Nanjing Medical University |
| Condition | Type 1 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2029-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-03-01 with a primary completion date of 2029-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Type 1 Diabetes Mellitus (T1DM).
Eligibility Criteria
Inclusion Criteria: Subjects must meet all of the following inclusion criteria to enter the study: 1. At the time of informed consent, male or non-pregnant or non-lactating female. 2. The diagnostic criteria for T1DM are confirmed by previous medical record. 3. The subject or his/her legal representative gives informed consent, fully nderstands the purpose of the study, is able to communicate effectively with the investigator, and comprehends and complies with the requirements set forth in the study. Exclusion Criteria: Subjects meeting any of the following exclusion criteria must be excluded from the study: 1. Diagnosed as any type of diabetes other than type 1 diabetes mellitus; 2. Subjects with severe life-threatening complications diabetes (such as ketoacidosis, or acute coronary syndrome, etc.); 3. At the time of screening, the subject or his/her legal representative refuses to take effective contraception within 3 months after the last treatment. 4. According to the judgment of the investigator, the subjects are not suitable to participate in this clinical study, or participation in this clinical study cannot guarantee the rights and interests of the subjects.
Contact & Investigator
Faming Zhang, PhD
PRINCIPAL INVESTIGATOR
The Second Hospital of Nanjing Medical University
Frequently Asked Questions
Who can join the NCT06256614 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 100 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06256614 currently recruiting?
Yes, NCT06256614 is actively recruiting participants. Contact the research team at fzhang@njmu.edu.cn for enrollment information.
Where is the NCT06256614 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT06256614 clinical trial?
NCT06256614 is sponsored by The Second Hospital of Nanjing Medical University. The principal investigator is Faming Zhang, PhD at The Second Hospital of Nanjing Medical University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.